Clinical implications of microbial biofilms in chronic rhinosinusitis and orbital cellulitis by unknown
RESEARCH ARTICLE Open Access
Clinical implications of microbial biofilms in
chronic rhinosinusitis and orbital cellulitis
Niranjan Nayak1,5*, Gita Satpathy1, Sujata Prasad1, Alok Thakar4, Mahesh Chandra2 and TC Nag3
Abstract
Background: Discovery of sessile mode of microbial existence (Biofilm state) focussed much interest, during the
recent years, on the study of biofilms in many recurring and chronic infections. However, the exact role of microbial
biofilms in chronic rhinosinusitis and orbital cellulitis were not elucidated earlier. The purpose of the present study
was to look for the adherent property and biofilm producing ability of the clinical isolates in chronic rhinosinusitis
and orbital cellulitis, and to look for the effects of antimicrobial agents on these biofilms by colorimetric assay and
ultrastructural analysis.
Methods: Organisms were isolated and identified from various clinical samples in patients with chronic sinusitis
and orbital cellulitis. Antimicrobial sensitivity testing was carried out by the standard protocol. Biofilms were
developed; quantified and antimicrobial drug perfusion through the biofilm model was evaluated by the earlier
devised procedure. Electronmicroscopic study of the biofilm was performed by the recommended technique.
Results: Of the total of 70 clinical samples processed, 48 i.e. 68.5 % grew bacteria and 13 i.e.(18.6 %) fungi. Staphylococcus
aureus (20), S epidermidis (16) and Pseudomonas aeruginosa (6) accounted for the majority of the bacterial isolates.
Aspergillus flavus (8), however was the commonest amongst the fungi. A total of 40 bacteria and 8 fungi could
be tested for biofilm production. Eighteen (45 %) of the 40 bacterial isolates and 4(50 %) out of the 8 A flavus
isolates were found to be biofilm producers. In vitro adherence testing revealed that majority i.e. 16 (88.8 %) of
the 18 biofilm positive bacteria were adherent to artificial surfaces. Antimicrobial drug perfusion through the
biofilm model was poor. Antimicrobial treatment was totally ineffective against strong biofilm producers, whose
electron microscopic picture was quite similar to that observed for biofilm producers without any antimicrobial
pre-treatment.
Conclusions: Filamentous fungi, like bacteria were capable of forming biofilms, which could be one of the
important virulence factors in determining the pathogenic potential of these organisms in causing chronic
rhinosinusitis and orbital cellulitis.
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Background
Biofims are highly organised microbial communities
enclosed within a self-produced extra cellular polymeric
matrix [1]. Biofilms, in an vivo situation, are highly re-
calcitrant to the defence mechanism of the body as well
as to antimicrobial therapy [2]. There are scanty reports
on the role of biofilms in acute fulminant infections
such as orbital cellulitis and severe form of chronic
rhinosinusitis(CRS).
Evidences in favour of biofilm producing organisms
contributing towards the pathogenesis of osteomyelitis,
and infections of various other cavities such as the pouch
of Douglas and dental root canals were documented earl-
ier [3]. However, the precise link between biofilm produc-
tion and development of sino-nasal and orbital infections
is still elusive, excepting that limited studies in the recent
past described the role of bacterial biofilms alone, and that
too in animal models of sinusitis [4].
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Thus it is important to extrapolate the behaviour of
the common bacterial and fungal pathogens causing
sino-nasal and orbital infections, looking towards their
biofilm forming abilities and other phenotypic character-
istics, so that new perspectives on the pathogenesis and
therapeutic modalities of such chronic as well as fulmin-
ant life threatening conditions, could be proposed.
This study was, therefore, planned with the aim of ex-
ploring the potential of the bacterial and fungal agents
causing orbital cellulitis and CRS to form biofilms, and
secondly to find out, if such biofilms could circumvent
the effect of antibacterial and antifungal agents by
restricting their entry through the sessile biofilm archi-
tecture in an in vitro model, designed in our laboratory.
Methods
The study was conducted in the department of Ocular
Microbiology of the All India Institute of Medical Sci-
ences, New Delhi, India after obtaining the informed
consent from the patients and the ethical clearance from
the Institute’s ethical committee.
Isolation and identification of pathogens from clinical
specimens
Specimen collection
Aspirates in case of orbital cellulitis were collected by
means of sterile syringe and needle with all aseptic pre-
cautions. Surrounding healthy skin was disinfected before
sample collection. Pus, wound and/or sinus discharge
were collected by rubbing the area with sterile cotton
tipped swabs. However, if material was found to be insuffi-
cient, the wound/sinus was squeezed and the purulent ex-
udates were collected. Thick brownish nasal discharge,
when present was obtained with the help of sterile cotton
swab. Eschar from the hard palate, if any, was collected by
vigorously rubbing the swab deep in the perforated area
of the hard palate. In lone cases of sinusitis nasal la-
vages/sinus wash materials were collected and immedi-
ately sent to the laboratory in sterile containers for
further processing.
A total of 70 samples were obtained which comprised
of 64 specimens of pus/aspirate/wound swab from cases
of orbital cellulitis with/without clinical and/or radio-
logic evidence of sinus involvement; and six specimens
(five sinus drains and one ethmoidal biopsy material)
from cases having sinusitis alone.
Processing of specimens
All samples were processed in the laboratory following
standard techniques. Direct microscopy on 10 % KOH
wet mount was performed for demonstration of fungal
elements in tissue. All specimens were cultured by in-
oculation onto Sabouraud’s dextrose agar (SDA) for
growth of fungi and conventional bacterial culture media
for growth of bacteria. Fungal isolates were identified by
lactophenol cotton blue wet mount, slide culture if needed
in case of mycelial fungi, and by germ tube test, pseudohy-
phae formation on corn meal agar and biochemical tests
(sugar fermentation and assimilation and nitrate assimila-
tion tests) for yeast species [5]. Bacteria were identified by
the recommended techniques by studying the colony
morphology on blood agar, chocolate agar and Mac
Conkey’s agar and by interpreting various biochemical
test results [6].
Testing for the phenotypic markers
Biofilm assay
In vitro adherence and biofilm formation by bacteria
The isolates were tested for their ability to adhere to
artificial surface and to form biofilms by adopting the
previously standardized techniques mentioned else-
where [7].
Development of bacterial biofilm model on polycarbonate
membrane
Biofilms were developed on 25 mm black polycarbonate
membrane as detailed previously [8], with minor modifi-
cations (Fig. 1). Antibiotic perfusion through the biofilm
developed on this membrane was performed as depicted
in step 2 of Fig. 1 [8].
Fungal biofilms Growth conditions and standardization
of conidial inoculum.
Fungi were grown on SDA at 37 °C for 72 h. Conidia
were harvested by flooding the surface of the agar plates
with 5 ml PBS (Oxoid) containing 0.025 % (v/v) Tween
20 and rocking gently. The conidial suspensions were re-
covered and dispensed into sterile glass containers. The
conidia were counted using a Neubauer haemocytometer
and adjusted to the required concentration in RPMI
1640 (Sigma) buffered to pH 7.0 with 0.165 M MOPS
{3-(N-morpholino) propane sulfonic acid}. All proce-
dures were carried out in a laminar flow cabinet as de-
scribed previously [9].
Biofilm formation
Fungal biofilms were formed on commercially available,
pre-sterilized, polystyrene, flat-bottomed, 96-well micro-
titre plates, according to the earlier described method
[9, 10]. Briefly, 200 μl of a standardized cell suspension
in MOPS-buffered RPMI 1640 were added to each well
for selected time periods (4, 8, 12, 24 and 48 h), and in-
cubated statically at 37 °C. A minimum of 12 replicates
were performed for each experimental parameter, along
with suitable controls. At each selected time point, the
medium was aspirated and the biofilms were washed
thoroughly three times with sterile PBS by repeated
gentle pipetting to remove non-adherent cells.
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Quantification of antifungal agents through fungal biofilms
Antifungal activity was quantified using an XTT reduc-
tion assay, as described before [9]. Cellular viability was
calculated as a function of metabolism, which was in-
dicated by a change of colour from orange to pink de-
pending on the relative viability of the filamentous
population [9]. The metabolic activity of each phase of
filamentous growth was quantified in a microtitre plate
reader (FLUOstar OPTIMA, BMG Labtech, Bucking-
hamshire, UK) at 490 nm. The XTT absorbance value,
after normalizing for back-ground absorbance levels,
was used to assess the effectiveness of each antifungal
agent relative to the unchallenged positive control. Ses-
sile MICs (SMICs) were determined by comparing the
intensity of colour change with the untreated control.
Testing of each isolate was performed in triplicate.
Ultrastructural analysis
Ultrastructural study was performed by electron micros-
copy of bacterial and fungal biofilms on polycarbonate
surfaces and also on antibiotic treated biofilm after devel-
oping antibiotic biofilm model represented schematically
vide Fig. 1. Biofilm, thus developed, was fixed with 5 %
glutaraldehyde, treated with Osmium tetroxide (OSO4)
and dehydrated with ethanol before being subjected to
electron microscopic study [11].
Antimicrobial sensitivity testing
The isolates were tested against antifungal agents accord-
ing to the guidelines laid down by CLSI (M-38A, USA).
Antibacterial sensitivity was performed by the recom-
mended Kerby Bauer disc diffusion method [12].
Development of biofilm model on polycarbonate membrane
For standardization, overnight bacterial culture in trypti-
case soy broth (TSB) was added to the black polycarbon-
ate membrane (25 mm diameter) on trypticase soy agar
(TSA) plate and incubated till 48 h at 37 °C for biofilm
development. Perfusion of antibiotic through the biofilm
was tested as per the protocol depicted in Fig. 1. The
same technique was adopted for fungal biofilm develop-
ment and for antifungal drug perfusion assay (Fig. 1).
Fig. 1 Quantitation of antimicrobial agents through Biofilm
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Results
A total of 70 samples were collected; 64 pus/aspirates, five
sinus drains and one ethmoidal biopsy material. Of the 64
orbital cellulitis specimens, 46 (72 %) yielded bacteria and
9 (14 %) grew fungi. The 46 bacterial isolates comprised of
20, Staphylococcus aures; 16, Staphylococcus epidermidis,
4, Pseudomonas aeruginosa, 4 aerobic spore bearing or-
ganisms and one each of Streptococcus pneumoniae and
Klebsiella pneumoniae. Out of the nine fungal apthogens
obtained from orbital cellulitis cases, four were Aspergillus
flavus, two Alternaria species and there was one each of
Curvularia, Fusarium and Candida albicans. All the six
samples from sinusitis cases were culture positive, show-
ing growth of Aspergillus flavus in four and Pseudomonas
aeruginosa in two. Overall, culture positivity for bacteria
was found in 68.5 % (48 of 70) of the cases and for fungi
in 18.6 % (13 of 70) cases.
Forty out of the total of 48 bacterial isolates were
tested for their biofilm production. These 40 comprised
of 20 isolates of Staphylococcus aureus, 16 Staphylococ-
cus epidermidis and 4 Pseudomonas aeruginosa (two
each from sinus and sino-orbital sites). All eight Asper-
gillus isolates were also tested for biofilm production. It
was noted that 18 (45 %) of the 40 bacteria were biofilm
positive. Majority of the biofilm producing organisms
(16/18 i.e. 88.8 %) were capable of adhering to polyster-
ene surfaces as compared to only 7 (31.8 %) of the total
of 22 non-biofilm producing organisms (Table 1). This
difference was found to be statistically significant.
Amongst the eight Aspergillus isolates,however, 4(50 %)
were noted to be biofilm producers.
Figure 2 depicts the results of the standardization of
antibiotic perfusion through the biofilm model, as de-
scribed in the methods. The standardization protocol
yielded optimum results showing clear zone of inhibition
beyond the black polycarbonate membrane when there
was no biofilm over the membrane. Similarly Fig. 3 doc-
uments a representative of the strain producing biofilm
that did not allow any perfusion of antibiotics, and
therefore, indicating no zone of inhibition surrounding
the polycabonate membrane. Subsequently all clinical
isolates were tested for antibiotic perfusion through their
biofilms developed in accordance with this standardized
technique.
Figure 4 demonstrates the antifungal drug (amphoter-
icin B) perfusion through Aspergillus biofilms devel-
oped on the black polycarbonate membranes. Panels A
through D show SDA plates with spore inoculum lawn
culture of all the eight clinical isolates of A flavus (two
isolates per plate), along with the biofilm model dem-
onstrating either inhibition or no inhibition of fungal
growth. It was interesting to note that only two (left
most sectors of plates shown in panels C and D) out of
the eight fungi exhibited moderate zones of inhibition
surrounding the disc, suggesting thereby that the rest
six isolates showing no inhibition zone were biofilm
producers. This finding was further authenticated by
Table 1 Adherence properties of the 40 bacteria tested for
biofilm production
Biofilm production Adherent Non-adherent Total
Biofilm positive 16 (88.9 %) 2 (11.1 %) 18
Biofilm negative 7 (31.8 %) 15 (68.2 %) 22
χ 2 = 13.12; p <0.001
Fig. 2 Control plate without biofilm which shows clear cut zone of
inhibition beyond the black poly carbonate membrane. The lawn
culture on the plate is that of a clinical isolate of Staphylococcus
epidermidis from a case of orbital cellulitis. Antibiotic disc is placed in
the centre
Fig. 3 Shows no zone of inhibition around the black poly carbonate
with the biofilm developed on it. Antibiotic disc is placed in
the centre
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the results of the XTT reduction assay (Fig. 5) which
demonstrated that four (upper four rows of either of
the microtiter plates) of those six isolates (Fig. 4) that
prevented amphotericin B perfusion through their bio-
films, had shown high MIC values (between 4 and
8 mg/L). The above findings bear important clinical im-
plications that A flavus capable of forming biofilm in
vivo in diseased conditions, would be recalcitrant to an-
tifungal medication, because cells in the interior of the
biofilm would be least exposed to the drug owing to in-
adequate drug perfusion through the biofilm matrix.
The absorbance values of the respective wells of the
XTT reduction assay have been shown in Table 2 that
exhibits increase in the absorbance values with relative
decrease in drug concentration.
Figure 6 represents antibiotic perfusion assay through
polycarbonate membrane with or without bacterial bio-
films as described in the methods. Panels a, d, A and D
Fig. 4 Antifungal drug perfusion through fungal biofilm on black polycarbonate membrane showing moderate zone of inhibition around the
left most discs of the lower two plates i.e. panels c and d, whereas in rest of the six sectors (two each in panels a and b; one each in panels c and d),
there is no zone of inhibition suggesting that antifungal agent did not perfuse through the biofilm developed on the polycarbonate membrane.
All the eight organisms tested were Aspergillus flavus isolates from orbital pus, sinus drain and biopsy materials
Fig. 5 XTT reduction assay to show resistance patterns of fungal biofilm to amphotericin B. Panels show the MIC results of six Aspergillus biofilms
(rows 1–6) in duplicate (Panel a and Panel b) showing amphotericin B MICs of 4,4,8,4,1 and 2 mg/L respectively in the rows 1, 2, 3, 4, 5 and 6. Strains in
the row 3 with MIC value of 8 mg/L was a strong biofilm producing organisms and those in the rows 1,2 and 4 were weak biofilm producers as shown
by the SEM study. Wells in the right most panels show positive controls without antifungal agent and those in the row below (labelled as “NC”) show
the negative controls i.e. dye alone without any organisms exhibiting no reduction of the dye and thus no color intensity
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are the controls without any biofilm on the polycarbonate
membranes, showing clear zones of inhibition of S epider-
midis lawn culture tested against gentamicin, cloxacillin,
vancomycin and ciprofloxacin respectively. Panels b, c, e, f
and B, C, E, F represent models in which biofilms were de-
veloped on the membranes. Whereas panels b,e and E
show clear zones of inhibition of bacteria surrounding the
biofilm, other panels like c, f, B, C and F show either no
zone or very minimal zone. Antibiotics tested on each
model have been named below the individual panels.
It was quite evident from the above mentioned obser-
vations that zones of inhibition due to antibiotic perfu-
sion across the biofilms was substantially less (or even
no zone at all) as compared to those produced by antibi-
otics perfusing through the membrane alone without
any biofilm overlying it. It will be noteworthy to mention
here that bacterial isolates showing either no zone or
very minimal zone of inhibition in the panels c, f, B, C
and F were strong biofilm producers. These strong bio-
films elaborated by the aforementioned five strains (in
the panels c, f, B, C, F) exhibited thick closely packed
cells framed in a sessile architecture, intimately attached
to one another as evidenced by the SEM analysis (Fig. 7
panels a and b). Interestingly, there was not much vari-
ation in the population density of cells of strong biofilm
producers whether they were treated or untreated with
antibiotics (Fig. 7, panel a vs. b). This suggested that
strong biofilm producing organisms resisted killing by
antimicrobial agents.
Discussion
Recent recognition of the ubiquitous nature of microbial
biofilms has generated much interest among the scien-
tific community in studying a number of infectious dis-
ease processes from a biofilm perspective. The riddle of
biofilm is due to its sessile mode of growth giving rise to
chronicity of infection and persistence of the organism
inside the core of the biofilm resulting in recalcitrance
towards antimicrobial chemotherapy [13]. Ventilator
associated pneumonias, prosthetic valve endocarditis,
periodontitis, bacterial keratitis, central venous catheter
related sepsis, late onset endophthalmitis following
intra-ocular lens implantation, prosthetic joint and other
orthopedic implant related infections and chronic lung
infections in cystic fibrosis are some of the examples of
diseases that are generally encountered to be associated
with microbial biofilms [13, 14]. These infections share
some common characteristics even though the microbial
causes and sites of infection in the host, show profound
variation. The most important implication of this process
is that micro-organisms in biofilms evade host defences
and withstand antimicrobial pressure.
As emphasized above, microbial biofilms having a sur-
vival advantage due to evasion of host immunity and un-
responsiveness to antimicrobial therapy, can give rise to
serious infections, especially among ICU patients im-
planted with indwelling medical devices. These infections
do not usually resolve unless the biofilm is dissolved or
the implant is removed, which in many cases is not cost
effective and sometimes, impracticable. Susceptibility tests
using in vitro biofilm models have shown the survival of
bacteria after treatment with antibiotics at concentrations
hundred or even thousand times the minimum inhibitory
concentration for the organism measured in a suspension
culture i.e. in its planktonic state [8–10]. Administration
of antimicrobial agents may suppress symptoms of infec-
tion by killing free floating organisms shed from the at-
tached population, but fail to eradicate those buried in the
interior of the biofilm. Soon after the antimicrobial
chemotherapy is omitted, the same biofilm acts as a po-
tential source for another spell of fresh infection leading
to recurrence and chronicity. However, in spite of the
aforementioned valuable information, studies on the im-
portance and clinical implications of bacterial and fungal
biofilms in CRS and orbital cellulitis were scanty.
In view of the aforementioned observations relating to
biofilm and microbial virulence in various systemic in-
fections, we tried to explore similar such occurrence in
CRS and orbital cellulitis. It was justifiable to study these
two disease entities together because these two are
Table 2 XTT Reduction assay results
Drug concentration in μg per ml
Lab. No 32 16 8 4 2 1 μ 0.5 0.25 Positive control Negative control
39/12/9 2.307 3.011 2.894 2.793 3.372 3.325 3.325 3.306 3.316 0.143
20/13/9 1.876 2.002 1.997 2.297 2.833 2.176 2.961 3.506 3.522 0.167
29/3/9 1.604 1.632 1.656 1.788 1.823 2.772 2.827 2.884 3.513 0.18
30/3/11 1.337 2.421 2.557 2.697 2.697 2.971 2.986 2.999 2.985 0.199
16/5/6 0.941 1.14 1.477 1.419 1.563 1.596 2.247 2.564 OVRFLW 0.047
19/15/12 1.499 1.499 1.512 1.516 2.555 2.794 2.819 3.436 3.538 0.098
21/15/12 0.941 1.14 1.477 1.419 1.563 1.596 2.247 2.564 OVEFLW 0.1
12/23/2011 1.559 1.776 2.667 3.14 3.241 3.256 3.312 3.323 3.113 0.145
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clinically very much inter-related so far as the pathogen-
esis of the later condition is concerned which often de-
velops as a complication of the former (frequently
ethmoidal sinusitis).
Cryer et al. [15] first suggested the presence of bio-
films on the sinus mucosa of CRS patients. This short
study of 16 CRS patients, who had failed to respond to
both surgical and medical treatments, utilised scanning
electron microscopy to analyse the specimens of sinus
mucosa. In their experiments, the researchers found four
specimens with a thicker coating than what is found in a
normal muco-ciliary blanket. Further studies on the
pathogenesis of various bacterial infections suggested
that bacteria could adhere to solid surfaces and form a
slimy, slippery coat. These, so called, bacterial biofilms
were prevalent on most wet surfaces, and bacterial cells
embedded inside biofilms were resistant to antimicrobial
agents and the host immune defence mechanism [15].
Ferguson and Stolz [16] demonstrated the presence of
bacterial biofilms in two of four patients with CRS. Also
using scanning electron microscopy (SEM) and trans-
mission electron microscopy (TEM), Sanclement et al.
[17] noted a prevalence of biofilms in 80 % of the muco-
sal biopsies of CRS patients. Further electron micro-
scopic research revealed the presence of biofilms in
silastic stents removed from the frontal sinus recess after
endoscopic sinus surgery [18]. We recently documented
with the help of SEM that S epidermidis strains isolated
from patients with invasive disease in the eye produced
slime and had the potential to adhere [7, 11]. However,
those were the isolates from infectious keratitis, and
not from cases of orbital cellulitis. In yet another study,
Imamura et al. [19] put forth the evidence of Fusarium
and Candida albicans biofilms on soft contact lenses,
though fungal biofilms were, then, not documented ei-
ther in orbital cellulitis or in sinusitis.
(See figure on previous page.)
Fig. 6 Shows antibiotic perfusion through various biofilm models developed on black polycarbonate membranes as described in the methods.
Panels a, d and A, D above represent the controls without any biofilm on the polycarbonate membranes, showing clear zones of inhibition of
bacterial culture tested against gentamicin, cloxacillin,vancomycin and ciprofloxacin respectively. Panels b, c, e, f and B, C, E, F represent models
in which biofilms were developed on the membranes. Whereas panels b, e and E show clear zones of inhibition of bacteria surrounding the
biofilm, other panels like c, f, B, C and F show either no zone or very minimal zone. Antibiotics tested on each model have been named below
the individual panels
Fig. 7 Panel a showing the SEM picture of strong biofilm producing bacteria on the black polycarbonate membrane that did not allow perfusion
of antibiotics, which is quite comparable in density to another strong biofilm without any antibiotic treatment (Panel b). SEM picture of polycarbonate
membrane alone has been depicted in panel c for comparison
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Unlike the above mentioned studies on SEM and TEM
claiming direct evidence of biofilms on tissue material
[16–18], the present study, however, provided informa-
tion that pathogens causing such infections were capable
of forming biofilm in vitro (Fig. 6). Our results were in
agreement with the findings shown by others [20]. Add-
itionally, our study highlighted that strong biofilms on
the polycarbonate membranes drastically resisted perfu-
sion of antimicrobial agents through them, a finding
much similar to those noted by others [8–10], who were
of the view that perfusion of all antimicrobial agents was
poor through the in vitro biofilm model. This perfusion
model could mimic the in vivo situation when organisms
producing biofilms either on indwelling medical devices
or inside deep body cavities like sinuses and orbit, could
give rise to chronic infections, unresponsive to anti-
microbial treatment.
However, unlike the recent progresses made over the
research on the effects of antibiotics on bacterial biofilm
[8, 13, 14, 20], fewer studies are available, estimating the
efficacy of antifungal drugs on fungal biofilms [21]. Re-
cently, Mowat et al. [9] reported that all antifungal drugs
tested, were at least 1000 times less effective in reducing
the overall metabolic activity of 90 % of Aspergillus fumi-
gatus biofilm cells as compared to their planktonic
counterparts. Whereas Mowat et al. [9] tested the anti-
fungal susceptibility of the organisms both in their ses-
sile as well as in their planktonic forms; our study did
not have any scope for comparison of the sessile MIC
values with the planktonic MICs. This drawback of the
present study could be attributed to the small sample
size yielding only a few fungal pathogens. Nevertheless,
the results of our study, could have definite indication
that organisms inside the biofilm could be far less sensi-
tive to antimicrobial agents than the planktonic cells, an
observation much in agreement with that of Hasan et al.
[22], who investigated Candida biofilms employing an in
vitro XTT reduction assay, and concluded that biofilm
formation was a stable character among clinical Can-
dida isolates and such biofilms played an important role
in persistence of infection. We assayed the biofilm pro-
ducing abilities of Aspergillus flavus clinical isolates by
adopting similar techniques as that of Hasan et al. [22],
but our study, not only projected on the potential of the
biofilm organisms to give rise to chronic persistent in-
fection, but also on their recalcitrant nature towards
commonly used antimicrobial agents in clinical practice.
The present study, thus, showed that majority of the ad-
herent organisms were biofilm producers. These results
are in concordance with those of other investigators [23],
who observed that S. epidermidis recovered from clinical
materials behaved differently from the commensal S. epi-
dermidis not only by the presence of the ica A and the ica
B adherence genes, but also by their tendency towards
phase variation, attachment to polymer surfaces, and cap-
abilities to produce biofilm. Frebourg et al. [24], recently,
documented that significantly higher number of the in-
fecting strains (sepsis and catheter related infections) of S.
epidermidis possessed the ica and mecA genes as com-
pared to the contaminating strains. On the contrary, our
study was neither related to a single pathogen like S epi-
dermidis, nor did we investigate to look for any molecular
markers of pathogenicity for the studied pathogens.
Despite that, our observations on the behaviour of fungal
and bacterial biofilms in disease pathogenesis and anti-
microbial resistance were the first of its kind from cases
with orbital cellulitis and/or CRS, suggesting that biofilm
formation could contribute to the chronicity of deep
seated infections located in the orbit and paranasal sinuses
and could help the organisms circumvent antimicrobial
pressure and defence mechanism in the host.
Conclusions
The recent discovery of biofilm formation in bacteria
and yeasts led to a better understanding of microbial
ecology and focussed new insights into the mechanisms
of virulence and persistence of these pathogens. How-
ever, of late, it was generally assumed that filamentous
fungi, some of which have a significant impact on our
health and economy, were incapable of forming biofilms.
In contrast to this assumption, we showed that surface-
associated filamentous fungi could form biofilms. Based
on these findings and on previous models utilising bac-
terial and yeast systems, we propose our preliminary hy-
pothesis that filamentous fungi were able to form
biofilms that could behave in a way much similar to that
exhibited by bacteria in perpetuating antimicrobial re-
sistance in a clinical setting. Future studies on the possi-
bilities of developing modalities to dissolve the biofilms
in vivo, would probably add further weapon to our ar-
senal in combating infections caused by these dangerous
pathogens.
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